SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640455-22-000055
Filing Date
2022-05-05
Accepted
2022-05-05 13:17:48
Documents
58
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q jnce-20220331.htm   iXBRL 10-Q 953801
2 EX-31.1 jnce03312022exhibit311.htm EX-31.1 9189
3 EX-31.2 jnce03312022exhibit312.htm EX-31.2 9197
4 EX-32.1 jnce03312022exhibit321.htm EX-32.1 7621
  Complete submission text file 0001640455-22-000055.txt   4751262

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnce-20220331.xsd EX-101.SCH 29532
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jnce-20220331_cal.xml EX-101.CAL 46926
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnce-20220331_def.xml EX-101.DEF 146473
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnce-20220331_lab.xml EX-101.LAB 439780
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnce-20220331_pre.xml EX-101.PRE 280184
52 EXTRACTED XBRL INSTANCE DOCUMENT jnce-20220331_htm.xml XML 773319
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37998 | Film No.: 22895289
SIC: 2836 Biological Products, (No Diagnostic Substances)